Exploration of the antibody-drug conjugate clinical landscape.
Maecker H, Jonnalagadda V, Bhakta S, Jammalamadaka V, Junutula JR.
MAbs. 2023 Jan-Dec;15(1):2229101. doi: 10.1080/19420862.2023.2229101.
An Acceptable Therapeutic Ratio.
Randall M.
Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):889. doi: 10.1016/j.ijrobp.2023.11.051. Epub 2024 Feb 22.
Inhaled corticosteroids: potency, dose equivalence and therapeutic index.
Daley-Yates PT.
Br J Clin Pharmacol. 2015 Sep;80(3):372-80. doi: 10.1111/bcp.12637. Epub 2015 May 28.
The Latest Research and Development into the Antibody-Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy.
Nakada T, Sugihara K, Jikoh T, Abe Y, Agatsuma T.
Chem Pharm Bull (Tokyo). 2019;67(3):173-185. doi: 10.1248/cpb.c18-00744.
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio.
van Gisbergen MW, Zwilling E, Dubois LJ.
Front Oncol. 2021 May 10;11:653621. doi: 10.3389/fonc.2021.653621. eCollection 2021.
Current approaches for the purification of antibody-drug conjugates.
Matsuda Y.
J Sep Sci. 2022 Jan;45(1):27-37. doi: 10.1002/jssc.202100575. Epub 2021 Sep 16.
The Therapeutic Index.
Smith LS, Khemani RG.
Pediatr Crit Care Med. 2018 Aug;19(8):775-776. doi: 10.1097/PCC.0000000000001652.
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.
Ha SYY, Anami Y, Yamazaki CM, Xiong W, Haase CM, Olson SD, Lee J, Ueno NT, Zhang N, An Z, Tsuchikama K.
Mol Cancer Ther. 2022 Sep 6;21(9):1449-1461. doi: 10.1158/1535-7163.MCT-22-0362.
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
Shen W, De Hoyos CL, Migawa MT, Vickers TA, Sun H, Low A, Bell TA 3rd, Rahdar M, Mukhopadhyay S, Hart CE, Bell M, Riney S, Murray SF, Greenlee S, Crooke RM, Liang XH, Seth PP, Crooke ST.
Nat Biotechnol. 2019 Jun;37(6):640-650. doi: 10.1038/s41587-019-0106-2. Epub 2019 Apr 29.
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppression.
Daley-Yates P, Brealey N, Thomas S, Austin D, Shabbir S, Harrison T, Singh D, Barnes N.
Br J Clin Pharmacol. 2021 Feb;87(2):483-493. doi: 10.1111/bcp.14406. Epub 2020 Jun 17.
